These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 31129792)

  • 21. Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis.
    Cavagna L; Caporali R; Klersy C; Ghio S; Albertini R; Scelsi L; Moratti R; Bonino C; Montecucco C
    J Rheumatol; 2010 Oct; 37(10):2064-70. PubMed ID: 20634241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of the REVEAL Prognostic Equation and Risk Score Calculator in Incident Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.
    Mullin CJ; Khair RM; Damico RL; Kolb TM; Hummers LK; Hassoun PM; Steen VD; Mathai SC;
    Arthritis Rheumatol; 2019 Oct; 71(10):1691-1700. PubMed ID: 31066998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An overlooked parameter in coronary slow flow phenomenon: whole blood viscosity.
    Cetin MS; Ozcan Cetin EH; Canpolat U; Aydın S; Temizhan A; Topaloglu S; Aras D; Aydogdu S
    Biomark Med; 2015; 9(12):1311-21. PubMed ID: 26612589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between YKL-40 and pulmonary arterial hypertension in systemic sclerosis.
    Furukawa T; Matsui K; Kitano M; Yokoyama Y; Sekiguchi M; Azuma N; Imai Y; Hirota S; Yamanishi K; Sano H
    Mod Rheumatol; 2019 May; 29(3):476-483. PubMed ID: 29788800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis.
    Becker MO; Kill A; Kutsche M; Guenther J; Rose A; Tabeling C; Witzenrath M; Kühl AA; Heidecke H; Ghofrani HA; Tiede H; Schermuly RT; Nickel N; Hoeper MM; Lukitsch I; Gollasch M; Kuebler WM; Bock S; Burmester GR; Dragun D; Riemekasten G
    Am J Respir Crit Care Med; 2014 Oct; 190(7):808-17. PubMed ID: 25181620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased biventricular longitudinal strain in patients with systemic sclerosis is mainly caused by pulmonary hypertension and not by systemic sclerosis per se.
    Lindholm A; Hesselstrand R; Rådegran G; Arheden H; Ostenfeld E
    Clin Physiol Funct Imaging; 2019 May; 39(3):215-225. PubMed ID: 30597705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry.
    Hinchcliff M; Khanna S; Hsu VM; Lee J; Almagor O; Chang RW; Steen V; Chung L;
    Semin Arthritis Rheum; 2015 Dec; 45(3):309-14. PubMed ID: 26210782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selenium and Copper as Biomarkers for Pulmonary Arterial Hypertension in Systemic Sclerosis.
    Sun Q; Hackler J; Hilger J; Gluschke H; Muric A; Simmons S; Schomburg L; Siegert E
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32630589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Assessment of plasma endothelin level measurement in systemic sclerosis].
    Schmidt J; Launay D; Soudan B; Hachulla E; de Groote P; Lambert M; Queyrel V; Morell-Dubois S; Hatron PY
    Rev Med Interne; 2007 Jun; 28(6):371-6. PubMed ID: 17291632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longterm Efficacy and Safety of Monotherapy versus Combination Therapy in Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Retrospective RESCLE Registry Study.
    Pestaña-Fernández M; Rubio-Rivas M; Tolosa-Vilella C; Guillén-Del-Castillo A; Freire M; Vargas-Hitos JA; Todolí-Parra JA; Rodríguez-Carballeira M; Marín-Ballvé A; Espinosa G; Colunga-Argüelles D; Ortego-Centeno N; Trapiella-Martínez L; Carbonell-Muñoz C; Pla-Salas X; Perales-Fraile I; Corbella X; Fonollosa-Pla V; Simeón-Aznar CP;
    J Rheumatol; 2020 Jan; 47(1):89-98. PubMed ID: 30770503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival in systemic sclerosis associated pulmonary arterial hypertension in the current treatment era-results from a nationwide study.
    Sarı A; Satış H; Ayan G; Küçükşahin O; Kalyoncu U; Fidancı AA; Ayvalı MO; Ata N; Ülgü MM; Birinci Ş; Akdoğan A
    Clin Rheumatol; 2024 Jun; 43(6):1919-1925. PubMed ID: 38676757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.
    Coghlan JG; Denton CP; Grünig E; Bonderman D; Distler O; Khanna D; Müller-Ladner U; Pope JE; Vonk MC; Doelberg M; Chadha-Boreham H; Heinzl H; Rosenberg DM; McLaughlin VV; Seibold JR;
    Ann Rheum Dis; 2014 Jul; 73(7):1340-9. PubMed ID: 23687283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is pulmonary arterial hypertension really a late complication of systemic sclerosis?
    Hachulla E; Launay D; Mouthon L; Sitbon O; Berezne A; Guillevin L; Hatron PY; Simonneau G; Clerson P; Humbert M;
    Chest; 2009 Nov; 136(5):1211-1219. PubMed ID: 19429720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.
    Argula RG; Karwa A; Lauer A; Gregg D; Silver RM; Feghali-Bostwick C; Schanpp LM; Egbert K; Usher BW; Ramakrishnan V; Hassoun PM; Strange C
    Ann Am Thorac Soc; 2017 May; 14(5):682-689. PubMed ID: 28282243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of echocardiographic and pulmonary function test measures improves sensitivity for diagnosis of systemic sclerosis-associated pulmonary arterial hypertension: analysis of 2 cohorts.
    Gladue H; Steen V; Allanore Y; Saggar R; Saggar R; Maranian P; Berrocal VJ; Avouac J; Meune C; Trivedi M; Khanna D
    J Rheumatol; 2013 Oct; 40(10):1706-11. PubMed ID: 23950183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary arterial hypertension in systemic sclerosis: a national inpatient analysis.
    Sami H; Sami F; Razok A; Dasgupta M; Gajjar R
    ARP Rheumatol; 2024; 3(2):95-100. PubMed ID: 38956992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The economic burden of systemic sclerosis related pulmonary arterial hypertension in Australia.
    Morrisroe K; Stevens W; Sahhar J; Ngian GS; Ferdowsi N; Hansen D; Patel S; Hill CL; Roddy J; Walker J; Proudman S; Nikpour M
    BMC Pulm Med; 2019 Nov; 19(1):226. PubMed ID: 31775705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity.
    Michelfelder M; Becker M; Riedlinger A; Siegert E; Drömann D; Yu X; Petersen F; Riemekasten G
    Clin Rheumatol; 2017 Feb; 36(2):381-390. PubMed ID: 28028682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subclinical coronary atherosclerosis, detected by computer tomography with coronary calcium score, and the occurrence of major cardiovascular events at 5 years of follow-up in a cohort of patients with systemic sclerosis.
    Rotondo C; Sciacca S; Rella V; Busto G; Colia R; Cantatore FP; Corrado A
    Eur J Intern Med; 2023 Sep; 115():62-69. PubMed ID: 37316356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Relationship between Blood Viscosity and Isolated Coronary Artery Ectasia.
    Çekici Y; Kılıç S; Saraçoğlu E; Çetin M; Veysel Düzen İ; Yılmaz M
    Acta Cardiol Sin; 2019 Jan; 35(1):20-26. PubMed ID: 30713396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.